Neurotrophic Growth Factors for the Treatment of Amyotrophic Lateral Sclerosis: Where Do We Stand?

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that results in progressive loss of motoneurons, motor weakness and death within 3–5 years after disease onset. Therapeutic options remain limited despite substantial number of approaches that have been tested clinically....

Descripción completa

Detalles Bibliográficos
Autores principales: Henriques, Alexandre, Pitzer, Claudia, Schneider, Armin
Formato: Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2010
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902233/
https://www.ncbi.nlm.nih.gov/pubmed/20592948
http://dx.doi.org/10.3389/fnins.2010.00032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902233/
https://www.ncbi.nlm.nih.gov/pubmed/20592948
http://dx.doi.org/10.3389/fnins.2010.00032

Ejemplares similares